After a Year of Lessons Learned, Michigan Looks to Expand Comprehensive Clinical Cancer Sequencing | GenomeWeb

One year after launching a clinical cancer sequencing protocol, the University of Michigan has sequenced more than 100 patients, identifying actionable results in about half. The team has recently launched a pediatric cancer sequencing pipeline for which it has sequenced around 10 patients, and it is also looking to scale up its adult cancer sequencing pipeline to be able to handle more than the 10 to 20 patients per month it currently analyzes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.